Kedi-B (02487.HK): CU-30101 (Local Lidocaine Diclofenac Cream) obtained the National Drug Administration Drug Marketing Approval.

Wisdom Financial APP News, Codc-B(02487.HK) issued an announcement that the group's CU-30101 (local external lidocaine dibucaine cream) has obtained the drug marketing approval from the National Medical Products Administration of the People's Republic of China (China).